Cargando…
Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011
Asymptomatic hepatitis E virus (HEV) infections have been found in blood donors from various European countries, but the natural course is rarely specified. Here, we compared the progression of HEV viraemia, serostatus and liver-specific enzymes in 10 blood donors with clinically asymptomatic genoty...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015460/ https://www.ncbi.nlm.nih.gov/pubmed/27608433 http://dx.doi.org/10.2807/1560-7917.ES.2016.21.35.30332 |
_version_ | 1782452442979368960 |
---|---|
author | Vollmer, Tanja Diekmann, Juergen Eberhardt, Matthias Knabbe, Cornelius Dreier, Jens |
author_facet | Vollmer, Tanja Diekmann, Juergen Eberhardt, Matthias Knabbe, Cornelius Dreier, Jens |
author_sort | Vollmer, Tanja |
collection | PubMed |
description | Asymptomatic hepatitis E virus (HEV) infections have been found in blood donors from various European countries, but the natural course is rarely specified. Here, we compared the progression of HEV viraemia, serostatus and liver-specific enzymes in 10 blood donors with clinically asymptomatic genotype 3 HEV infection, measuring HEV RNA concentrations, plasma concentrations of alanine/aspartate aminotransferase, glutamate dehydrogenase and bilirubin and anti-HEV IgA, IgM and IgG antibodies. RNA concentrations ranged from 77.2 to 2.19×10(5) IU/mL, with viraemia lasting from less than 10 to 52 days. Donors showed a typical progression of a recent HEV infection but differed in the first detection of anti-HEV IgA, IgM and IgG and seropositivity of the antibody classes. The diagnostic window between HEV RNA detection and first occurrence of anti-HEV antibodies ranged from eight to 48 days, depending on the serological assay used. The progression of laboratory parameters of asymptomatic HEV infection was largely comparable to the progression of symptomatic HEV infection, but only four of 10 donors showed elevated liver-specific parameters. Our results help elucidate the risk of transfusion-associated HEV infection and provide a basis for development of screening strategies. The diagnostic window illustrates that infectious blood donors can be efficiently identified only by RNA screening. |
format | Online Article Text |
id | pubmed-5015460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-50154602016-09-28 Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011 Vollmer, Tanja Diekmann, Juergen Eberhardt, Matthias Knabbe, Cornelius Dreier, Jens Euro Surveill Research Article Asymptomatic hepatitis E virus (HEV) infections have been found in blood donors from various European countries, but the natural course is rarely specified. Here, we compared the progression of HEV viraemia, serostatus and liver-specific enzymes in 10 blood donors with clinically asymptomatic genotype 3 HEV infection, measuring HEV RNA concentrations, plasma concentrations of alanine/aspartate aminotransferase, glutamate dehydrogenase and bilirubin and anti-HEV IgA, IgM and IgG antibodies. RNA concentrations ranged from 77.2 to 2.19×10(5) IU/mL, with viraemia lasting from less than 10 to 52 days. Donors showed a typical progression of a recent HEV infection but differed in the first detection of anti-HEV IgA, IgM and IgG and seropositivity of the antibody classes. The diagnostic window between HEV RNA detection and first occurrence of anti-HEV antibodies ranged from eight to 48 days, depending on the serological assay used. The progression of laboratory parameters of asymptomatic HEV infection was largely comparable to the progression of symptomatic HEV infection, but only four of 10 donors showed elevated liver-specific parameters. Our results help elucidate the risk of transfusion-associated HEV infection and provide a basis for development of screening strategies. The diagnostic window illustrates that infectious blood donors can be efficiently identified only by RNA screening. European Centre for Disease Prevention and Control (ECDC) 2016-09-01 /pmc/articles/PMC5015460/ /pubmed/27608433 http://dx.doi.org/10.2807/1560-7917.ES.2016.21.35.30332 Text en This article is copyright of The Authors, 2016. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Research Article Vollmer, Tanja Diekmann, Juergen Eberhardt, Matthias Knabbe, Cornelius Dreier, Jens Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011 |
title | Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011 |
title_full | Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011 |
title_fullStr | Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011 |
title_full_unstemmed | Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011 |
title_short | Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011 |
title_sort | hepatitis e in blood donors: investigation of the natural course of asymptomatic infection, germany, 2011 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015460/ https://www.ncbi.nlm.nih.gov/pubmed/27608433 http://dx.doi.org/10.2807/1560-7917.ES.2016.21.35.30332 |
work_keys_str_mv | AT vollmertanja hepatitiseinblooddonorsinvestigationofthenaturalcourseofasymptomaticinfectiongermany2011 AT diekmannjuergen hepatitiseinblooddonorsinvestigationofthenaturalcourseofasymptomaticinfectiongermany2011 AT eberhardtmatthias hepatitiseinblooddonorsinvestigationofthenaturalcourseofasymptomaticinfectiongermany2011 AT knabbecornelius hepatitiseinblooddonorsinvestigationofthenaturalcourseofasymptomaticinfectiongermany2011 AT dreierjens hepatitiseinblooddonorsinvestigationofthenaturalcourseofasymptomaticinfectiongermany2011 |